All companies › LGND

LGND · LIGAND PHARMACEUTICALS INC

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells12
Research cases0
Last filing2026-10-02

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-03 — Reardon Andrew · sold 300 @ $283.99 2026-09-03 — Reardon Andrew · sold 1,800 @ $285.17 2026-09-03 — Reardon Andrew · sold 2,115 @ $286.36 2026-09-03 — Reardon Andrew · sold 385 @ $287.53 2026-09-03 — Reardon Andrew · sold 400 @ $288.98 2026-09-10 — Zimmermann Martine · sold 1,200 @ $285.00 2026-10-02 — Reardon Andrew · sold 833 @ $302.51 2026-10-02 — Reardon Andrew · sold 1,976 @ $303.54 2026-10-02 — Reardon Andrew · sold 1,535 @ $304.52 2026-10-02 — Reardon Andrew · sold 404 @ $306.18 2026-10-02 — Reardon Andrew · sold 235 @ $307.19 2026-10-02 — Reardon Andrew · sold 17 @ $307.74
2026-09-032026-10-02

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Reardon Andrew CLO & Secretary
Zimmermann Martine Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $LGND is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 833.0, 'price': 302.5107, 'value': 251991.41, 'is_buy': False}, {'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 1976.0, 'price': 303.5444, 'value': 599803.73, 'is_buy': False}, {'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 1535.0, 'price': 304.5154, 'value': 467431.14, 'is_buy': False}, {'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 404.0, 'price': 306.1834, 'value': 123698.09, 'is_buy': False}, {'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 235.0, 'price': 307.1911, 'value': 72189.91, 'is_buy': False}, {'transaction_date': '2026-10-02', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 17.0, 'price': 307.74, 'value': 5231.58, 'is_buy': False}, {'transaction_date': '2026-09-10', 'insider_name': 'Zimmermann Martine', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1200.0, 'price': 285.0, 'value': 342000.0, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 300.0, 'price': 283.9854, 'value': 85195.62, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 1800.0, 'price': 285.1671, 'value': 513300.78, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 2115.0, 'price': 286.3589, 'value': 605649.07, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 385.0, 'price': 287.5253, 'value': 110697.24, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Reardon Andrew', 'insider_title': 'CLO & Secretary', 'transaction_type': 'Open-market sell', 'shares': 400.0, 'price': 288.9792, 'value': 115591.68, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for LGND today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.